Vandral Retard (venlafaxine extended release) in depressive syndrome with anxiety and painful symptoms in elderly patients. observational study in primary care.

Trial Profile

Vandral Retard (venlafaxine extended release) in depressive syndrome with anxiety and painful symptoms in elderly patients. observational study in primary care.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2009

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Depressive disorders
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 10 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top